Literature DB >> 7682703

En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.

A J Muller1, A M Pendergast, K Parmar, M H Havlik, N Rosenberg, O N Witte.   

Abstract

Src homology region 2 (SH2) domains are present in many proteins involved in signal transduction. In nonreceptor protein tyrosine kinases the SH2 domain has been implicated in regulation of tyrosine kinase activity and in mediating interactions involved in downstream signaling. Different SH2 domains exhibit distinct binding specificities for both phosphotyrosine- and phosphoserine/phosphothreonine-containing proteins. We show that different SH2 domains are not functionally equivalent within the context of the c-ABL1b protooncogene. c-ABL1b, altered by replacement of its SH2 domain with the N-terminal SH2 domain of Ras GTPase-activating protein, exhibited activated transforming capability, caused intracellular tyrosine phosphorylation of p62, and was relocalized from nucleus to cytoplasm. This en bloc substitution apparently uncouples two distinct functions of the SH2 domain so that c-ABL escapes normal regulatory control while it retains the capability to elicit signals that promote transformation. The SH2 domain of the ARG protein tyrosine kinase, which shares high amino acid-sequence homology with the SH2 domain of ABL, was less effective in activating the oncogenic potential of c-ABL. The effects that the N-terminal SH2 domain of Ras GTPase-activating protein has in the context of c-ABL resemble the effects of deleting the SH3 domain. Thus, the SH2 and SH3 domains may have coordinate roles as regulatory control elements within the context of c-ABL.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682703      PMCID: PMC46319          DOI: 10.1073/pnas.90.8.3457

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.

Authors:  C A Cartwright; W Eckhart; S Simon; P L Kaplan
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

2.  A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps.

Authors:  I Sadowski; J C Stone; T Pawson
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

3.  Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.

Authors:  E Shtivelman; B Lifshitz; R P Gale; B A Roe; E Canaani
Journal:  Cell       Date:  1986-10-24       Impact factor: 41.582

4.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.

Authors:  T E Kmiecik; D Shalloway
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

5.  Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src.

Authors:  H Piwnica-Worms; K B Saunders; T M Roberts; A E Smith; S H Cheng
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

6.  Transfected DNA is mutated in monkey, mouse, and human cells.

Authors:  J S Lebkowski; R B DuBridge; E A Antell; K S Greisen; M P Calos
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

7.  Alternative 5' exons in c-abl mRNA.

Authors:  Y Ben-Neriah; A Bernards; M Paskind; G Q Daley; D Baltimore
Journal:  Cell       Date:  1986-02-28       Impact factor: 41.582

8.  Definition of regions in human c-myc that are involved in transformation and nuclear localization.

Authors:  J Stone; T de Lange; G Ramsay; E Jakobovits; J M Bishop; H Varmus; W Lee
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

9.  Enzymatic activation of Fujinami sarcoma virus gag-fps transforming proteins by autophosphorylation at tyrosine.

Authors:  K Meckling-Hansen; R Nelson; P Branton; T Pawson
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

10.  Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus.

Authors:  A B Reynolds; J Vila; T J Lansing; W M Potts; M J Weber; J T Parsons
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

View more
  6 in total

1.  The carboxyl terminus of v-Abl protein can augment SH2 domain function.

Authors:  D Warren; A J Heilpern; K Berg; N Rosenberg
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF.

Authors:  R Plattner; L Kadlec; K A DeMali; A Kazlauskas; A M Pendergast
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

3.  Structure, regulation, signaling, and targeting of abl kinases in cancer.

Authors:  Oliver Hantschel
Journal:  Genes Cancer       Date:  2012-05

4.  Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.

Authors:  B J Mayer; D Baltimore
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

5.  Oncogenic activation of c-ABL by mutation within its last exon.

Authors:  A Goga; J McLaughlin; A M Pendergast; K Parmar; A Muller; N Rosenberg; O N Witte
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

6.  Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma.

Authors:  Sarah Tannenbaum-Dvir; Julia L Glade Bender; Alanna J Church; Katherine A Janeway; Marian H Harris; Mahesh M Mansukhani; Peter L Nagy; Stuart J Andrews; Vundavalli V Murty; Angela Kadenhe-Chiweshe; Eileen P Connolly; Andrew L Kung; Filemon S Dela Cruz
Journal:  Cold Spring Harb Mol Case Stud       Date:  2015-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.